January 2025 Newsletter

The Power of Partnership?

At Cytovance, we are continuously optimizing our CDMO model to provide you with end-to-end services and custom manufacturing solutions. In response to the growing demand for peptide therapeutics, we recently announced our collaboration with PolyPeptide Group. Our teams have partnered before on specific customer projects, and we are excited to formally combine our expertise in microbial and mammalian expression, process development, and cGMP manufacturing with PolyPeptide’s capabilities in complex peptide development and manufacturing. If you want to explore how access to our complementary portfolios can advance and deliver your drug development projects, contact our team HERE.?

The Growing Innovation Ecosystem in OKC

This week, we joined other members of the Oklahoma City community in celebrating the launch of the Innovation Hall at the OKC Innovation District 2025 Innovation Breakfast. This dynamic hub will house BioTC Oklahoma and other exciting biotech and science organizations.?New projects like these are one of the many reasons we chose to call the OKC Innovation District (OKCID), a vibrant ecosystem that drives economic growth and nurtures groundbreaking R&D, our home. ?

We are proud to have sponsored this year's Innovation Breakfast where Sharina Perry , the Founder and CEO of Utopia Plastix? ,?received the Innovation Impact Award for her leadership in plant-based alternatives for petroleum-based plastics. The event also included special remarks from:? ?

• Lt. Governor Matt Pinnell | State of Oklahoma

• Jeffrey Seymour, CEcD | CEO of OKCID?

• Carly Collins | Senior Director of Programs and Outreach, OKCID?

• Monique Walker | Manager of Partner Engagement and Special Projects, OKCID?

• Jessica Johnson | Principal of Thelma Parks?Elementary?

• Koey Keylon | Executive Director of BIOTC?

Welcome Back, Sudha Ankala?

We are pleased to announce that Sudha Ankala, Ph.D, PMP has rejoined Cytovance as our new Senior Director of Program Management. Sudha brings over 19 years of experience in technical planning and portfolio/program management in matrix Biotech environments to our team. Her career has taken her to notable pharma and biotech companies, including her most recent position as the Associate Director of CMC Program Management at Rocket Pharmaceuticals .

Sudha’s proven record in successful drug development and manufacturing includes multiple modalities across pre-clinical to commercial phases, achieving fast-track designation, health authority filing acceptances, and shepherding product launch preparations. Her talents and commitment to client success make her an excellent partner to help guide your 2025 programs!

Career Opportunities at Cytovance?

We are looking for passionate individuals to join Team Cytovance. If you or someone you know would be interested in a career that makes an everyday impact on global health through biomanufacturing we would love to hear from you. Check out our open positions HERE.?

Connect With Us at These Upcoming Conferences??

Fresh off JPM Week, we are headed to New York for #BIOCEO25. If you plan to attend, we invite you to meet with our team about agile solutions for your large molecule development and cGMP manufacturing needs.?

Schedule a meeting with our experts HERE.?

• BIO CEO and Investor Conference: February 10-11, 2025, New York, NY?

• BPI West: March 18-21, 2025, San Diego, CA?

• American Biomanufacturing Summit: April 15-16, 2025, San Francisco, CA?

• Festival of Biologics: April 23-24, 2024, San Diego, CA?

• BIO International Convention: June 16-19, 2025, Boston, MA?

• BPI East: September 15 -18, 2025, Boston, MA?